+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Eisai Co - logo

Eisai Limited is a research-based pharmaceutical company that develops, manufactures, and markets healthcare products for patients and their families. It offers products in the areas of Alzheimer's disease, gastrointestinal disorders, epilepsy, cervical dystonia, severe chronic pain, and oncology. The company was founded in 1988 and is based in Hatfield, United Kingdom. It also has operations in the United States, Asia, and Europe.

Pheochromocytoma Global Market Report 2024 - Product Thumbnail Image

Pheochromocytoma Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Anti-Neoplastic Agents Global Market Report 2024 - Product Thumbnail Image

Anti-Neoplastic Agents Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Anaplastic Astrocytoma Global Market Report 2024 - Product Thumbnail Image

Anaplastic Astrocytoma Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Solid Tumor Cancer Treatment Global Market Report 2024 - Product Thumbnail Image

Solid Tumor Cancer Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Myeloproliferative Disorders Drugs Global Market Report 2024 - Product Thumbnail Image

Myeloproliferative Disorders Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Metastatic Breast Cancer Treatment Global Market Report 2024 - Product Thumbnail Image

Metastatic Breast Cancer Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Urothelial Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Urothelial Cancer Drugs Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
From
From
From
Blood Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Blood Cancer Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Broad Spectrum Chemokine Inhibitor (BSCIs) - Pipeline Insight, 2024 - Product Thumbnail Image

Broad Spectrum Chemokine Inhibitor (BSCIs) - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
From
Loading Indicator